Medicover AB
OTC:MCVEF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/S
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Valuation Scenarios
If P/S returns to its 3-Year Average (1.3), the stock would be worth $28.56 (5% upside from current price).
| Scenario | P/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 1.2 | $27.25 |
0%
|
| 3-Year Average | 1.3 | $28.56 |
+5%
|
| 5-Year Average | 1.3 | $29.75 |
+9%
|
| Industry Average | 1.7 | $37.51 |
+38%
|
| Country Average | 2 | $43.87 |
+61%
|
Forward P/S
Today’s price vs future revenue
| Today's Market Cap | Revenue | Forward P/S | ||
|---|---|---|---|---|
|
$29.3B
|
/ |
Jan 2026
€2.4B
|
= |
|
|
$29.3B
|
/ |
Dec 2026
€2.7B
|
= |
|
|
$29.3B
|
/ |
Dec 2027
€3B
|
= |
|
|
$29.3B
|
/ |
Dec 2028
€3.3B
|
= |
|
|
$29.3B
|
/ |
Dec 2029
€3.8B
|
= |
|
|
$29.3B
|
/ |
Dec 2030
€4.2B
|
= |
|
Forward P/S shows whether today’s P/S still looks high or low once future revenue are taken into account.
Peer Comparison
| Market Cap | P/S | P/E | ||||
|---|---|---|---|---|---|---|
| SE |
|
Medicover AB
OTC:MCVEF
|
29.1B USD | 1.2 | 37.7 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
106.6B USD | 0.3 | 60.3 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
71B EUR | 0.3 | 13.7 | |
| US |
|
Cigna Corp
NYSE:CI
|
77B USD | 0.3 | 12.9 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
23.3B EUR | 1 | 18.4 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.5B EUR | 1.1 | 22.9 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21B USD | 1.9 | 20.6 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.1B USD | 1.5 | 24.1 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.6B EUR | 0.5 | 10.9 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
10.9B USD | 11.1 | -26.2 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.4B USD | 0.8 | 14 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 1.2 |
| Median | 2 |
| 70th Percentile | 4.4 |
| Max | 13 940.4 |
Other Multiples
Medicover AB
Glance View
Medicover AB, founded in 1995, is a prominent healthcare and diagnostic service provider, chiefly operating across Europe and India. The company, based out of Sweden, has carved a niche by offering a broad range of healthcare services, focusing on accessible and premium quality care. Medicover’s structure is multifaceted—comprising two main divisions: Healthcare Services and Diagnostic Services. Their healthcare division administers preventative and primary care services through outpatient clinics, as well as specialist hospital care, emphasizing a holistic approach to patient care. Meanwhile, the Diagnostic Services division performs a vital role, supplying an extensive array of laboratory and imaging services. This dual-pronged business model ensures a steady stream of revenue, bolstering Medicover’s position in the competitive healthcare landscape. The way Medicover makes money is intricately tied to its wide-reaching network and comprehensive service offerings. Revenues are primarily derived from the fees for healthcare and diagnostic services provided directly to patients and through contracts with insurance companies and corporate clients, who seek Medicover’s expertise in employee health management. In navigating the healthcare sector, Medicover leverages its robust technological infrastructure to optimize service delivery and operational efficiency, ensuring patient satisfaction while maintaining cost-effectiveness. By continuously expanding its geographical footprint and diversifying its service portfolio, Medicover is adept at adapting to evolving market demands, thus securing its long-term financial sustainability and reinforcing its commitment to delivering value-driven healthcare solutions.